Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Oct 13, 2026

OM — Outset Medical, Inc. Dilution Risk Tracker

Track OM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OM — Get alerts when the score changes →

As of October 13, 2026, Outset Medical, Inc. (OM) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Outset Medical, Inc. has a market capitalization of $75.38M, 18.80M shares outstanding, 99 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for OM.
🔔 Track OM — Get forecast alerts →

Market Data

Market Cap$75.38M
Shares Outstanding18.80M
Float15.59M
Cash$147.19M
Debt$102.40M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore36/100DilutionWatch score record
Shares Outstanding18.80MVerified float table or market cache
Public Float15.59MVerified float table or market cache
Market Cap$75.38MMarket data cache
Cash Runway13.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: FORM 4 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 16.5% shares (2026Q1 vs prior)
99 institutional holders · 18.12M shares
#1 FMR LLC 2.74M shares
#2 BML Capital Management, LLC 1.90M shares
#3 PERCEPTIVE ADVISORS LLC 1.67M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest792.7K
Days to Cover5.9
% of Float5.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-02-13
xbrl XBRL WARRANT 2026-02-13
Form 4 INSIDER TRANSACTION 2026-10-02
Form 4 INSIDER TRANSACTION 2026-10-01
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual OM Dilution Snapshot

Outset Medical, Inc. (OM) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

OM's DilutionScore is currently 36/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 37/100 (Medium risk).

Period Score Risk Level Duration
Sep 17 – Oct 13, 202636/100MEDIUM27 days
Aug 22 – Sep 16, 202637/100MEDIUM26 days
Jul 17 – Aug 21, 202636/100MEDIUM35 days
Jul 16, 202637/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

OM shares outstanding have increased 1.2% from 18.31M (Mar 2026) to 18.54M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 21, 202618.54M15.59M▼ 2.03%
May 18, 202618.54M15.91M▲ 22.67%
May 15, 202618.54M12.97M▼ 2.22%
May 11, 202618.54M13.27M▲ 0.02%
May 10, 202618.54M13.26M▲ 0.04%
May 09, 202618.54M13.26M▲ 1.19%
May 03, 202618.53M13.10M▲ 0.47%
Apr 28, 202618.53M13.04M▼ 0.14%
Mar 27, 202618.31M13.06M▼ 0.04%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track OM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment OM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking OM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Med Devices sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for OM
OM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.